Eurozone QE helped increase R&D spending, paper finds


Eurozone firms that receive quantitative easing funding have increased their research and development (R&D) spending, a working paper published by the European Central Bank finds.

In Quantitative easing and corporate innovation, Niklas Grimm, Luc Laeven and Alexander Popov examine companies eligible for the ECB’s corporate sector purchase programme (CSPP). Under the CSPP, the ECB buys the debt of large, publicly listed eurozone firms.

Firms that had their debt purchased by the ECB increased

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Central Banking account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: